Margaret Kindlen
- Molecular Biology
- Oncology top 10%
- Pharmacology top 5%
- Pharmacology top 10%
- Neurology top 10%
- Co-authors
- Howard L. McLeodWanghai ZhangGuang XuMichael H. WooJohn F. DiPersioPeter WesterveltTimothy J. LeyVictor M. Santana
- Topics
- Cancer therapeutics and mechanisms (3 papers)Pharmacogenetics and Drug Metabolism (3 papers)Acute Myeloid Leukemia Research (2 papers)
- Cited by
- PharmacologyOncologyHematology
- Partner nations
- United States
In The Last Decade
Margaret Kindlen
11 papers receiving 815 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 478
- Oncology 269
- Pharmacology 117
- Pharmacology 115
- Neurology 101
Countries citing papers authored by Margaret Kindlen
This map shows the geographic impact of Margaret Kindlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Kindlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Kindlen more than expected).
Fields of papers citing papers by Margaret Kindlen
This network shows the impact of papers produced by Margaret Kindlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Kindlen. The network helps show where Margaret Kindlen may publish in the future.
Co-authorship network of co-authors of Margaret Kindlen
This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Kindlen. A scholar is included among the top collaborators of Margaret Kindlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Kindlen. Margaret Kindlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report. | 20 |
| 4 | 95 | |
| 5 | 36 | |
| 6 | Human carboxylesterase 2 is commonly expressed in tumor tissue and is correlated with activation of irinotecan. | 248 |
| 7 | 3 | |
| 8 | 190 | |
| 9 | Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecan. | 50 |
| 10 | 185 | |
| 11 | 6 |
About Margaret Kindlen
Margaret Kindlen is a scholar working on Pharmacology, Oncology and Hematology, having authored 11 papers that have together received 842 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Pharmacology (117 citations), Oncology (269 citations) and Hematology (85 citations). Margaret Kindlen has collaborated with scholars based in United States. Frequent co-authors include Howard L. McLeod, Wanghai Zhang, Guang Xu, Michael H. Woo, John F. DiPersio, Peter Westervelt, Timothy J. Ley, Victor M. Santana, Clinton F. Stewart and Wayne L. Furman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.